Ποια είναι η τιμή για Stimcell Energetics, Inc. (STME)

Η τιμή για Stimcell Energetics, Inc. (STME) είναι $0.3

Ποια είναι η κεφαλαιοποίηση αγοράς για Stimcell Energetics, Inc. (STME)

Η κεφαλαιοποίηση αγοράς για Stimcell Energetics, Inc. (STME) είναι $6.34M

Stimcell Energetics, Inc. (STME) Τιμή και Κεφαλαιοποίηση Αγοράς

StimCell Energetics Inc. is a biotechnology company focused on the research, development, and market introduction of both therapeutic and non-therapeutic solutions. These products are intended to benefit individuals in the United States who are managing conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and issues with kidney function. The company's primary product line is the eBalance system, which comprises two versions: the eBalance Pro System, designed for clinical application by healthcare practitioners, and the eBalance Home System, created for personal use to promote overall well-being and alleviate pain. Both systems are operated via the eBalance Console, a central control unit that offers three distinct pre-programmed microcurrent algorithms: one for general wellness, another for pain relief, and a 'dual' mode that combines both. Additionally, these eBalance products aim to provide temporary relief for discomfort in various body parts, including the shoulders, waist, back, neck, arms, and legs. Established in 2010, the company initially operated under the name Cell MedX Corp. before officially rebranding as StimCell Energetics Inc. in November 2024. Its corporate headquarters are located in Vancouver, Canada.

Η τιμή για STME	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$257,868 $6.34M	NVDA	$5.452T	+85,955,977.16%
$212,374 $6.34M	AAPL	$4.490T	+70,791,147.88%
$196,878 $6.34M	GOOG	$4.162T	+65,625,882.94%
$173,888 $6.34M	MSFT	$3.676T	+57,962,416.67%
$134,000 $6.34M	AMZN	$2.833T	+44,666,653.20%

Η τιμή για STME

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$257,868 $6.34M